Akira I. Hida
-
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 4
- Pancreatic and Hepatic Oncology Research 3
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 4
-
- Breast Lesions and Carcinomas 2
-
- Immunotherapy and Immune Responses 3
-
- Parvovirus B19 Infection Studies 2
- Co-authors
- Yumi OshiroYoshiaki SagaraYasuyo OhiKenjiro AogiYasuaki SagaraTakuya MoriyaNatsumi YamashitaHiromichi Inoue
- Cited by
- OncologyCancer ResearchRheumatology
- Journals
- Free Radical Biology and Medicine (1 paper)The Journal of Pediatrics (1 paper)Journal of Clinical Pathology (1 paper)
- Partner nations
- JapanDenmarkUnited States
In The Last Decade
Akira I. Hida
18 papers receiving 359 citations
Peers
Comparison fields: 5 of 51
- Oncology 193
- Cancer Research 82
- Rheumatology 61
- Pathology and Forensic Medicine 67
- Immunology 62
Countries citing papers authored by Akira I. Hida
This map shows the geographic impact of Akira I. Hida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira I. Hida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira I. Hida more than expected).
Fields of papers citing papers by Akira I. Hida
This network shows the impact of papers produced by Akira I. Hida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira I. Hida. The network helps show where Akira I. Hida may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Akira I. Hida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2021 | 0 | |
| 3 | 2020 | 14 | |
| 4 | 2019 | 26 | |
| 5 | 2019 | 33 | |
| 6 | 2019 | 32 | |
| 7 | 2018 | 3 | |
| 8 | 2018 | 16 | |
| 9 | 2018 | 13 | |
| 10 | 2017 | 29 | |
| 11 | 2017 | 1 | |
| 12 | 2016 | 50 | |
| 13 | 2015 | 19 | |
| 14 | Case Report: Cytomegalovirus proctitis in a patient with idiopathicinterstitial pneumonia. | 2014 | 0 |
| 15 | 2013 | 26 | |
| 16 | 2012 | 65 | |
| 17 | [B-cell lymphoma possessing t(14;18)(q32;q21)in a patient with rheumatoid arthritis receiving methotrexate treatment]. | 2011 | 0 |
| 18 | 2009 | 11 | |
| 19 | 2009 | 3 | |
| 20 | 2003 | 15 |
About Akira I. Hida
Akira I. Hida is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 21 papers that have together received 365 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (4 papers), Breast Cancer Treatment Studies (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Immunotherapy and Immune Responses (3 papers), Breast Lesions and Carcinomas (2 papers), Parvovirus B19 Infection Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (193 citations), Cancer Research (82 citations) and Rheumatology (61 citations). Akira I. Hida has collaborated with scholars based in Japan, Denmark and United States. Frequent co-authors include Yumi Oshiro, Yoshiaki Sagara, Yasuyo Ohi, Kenjiro Aogi, Yasuaki Sagara, Takuya Moriya, Natsumi Yamashita, Hiromichi Inoue, Yukie Fujimoto and Michiko Imamura. Their work appears in journals such as Free Radical Biology and Medicine, The Journal of Pediatrics and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.